G. Martignoni

689 total citations
24 papers, 429 citations indexed

About

G. Martignoni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, G. Martignoni has authored 24 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Genetics. Recurrent topics in G. Martignoni's work include Colorectal Cancer Treatments and Studies (10 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Gastric Cancer Management and Outcomes (6 papers). G. Martignoni is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Gastric Cancer Management and Outcomes (6 papers). G. Martignoni collaborates with scholars based in Italy and Switzerland. G. Martignoni's co-authors include Bianca Marasini, Marco Cicardi, A Agostoni, Luigi Bergamaschini, Sandro Barni, Roberto Labianca, Angelo Agostoni, Alberto Zaniboni, Stefano Cascinu and L. Frontini and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of Allergy and Clinical Immunology.

In The Last Decade

G. Martignoni

22 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Martignoni Italy	8	179	173	149	108	82	24	429
Agnieszka Szymczyk Poland	9	115 0.6×	86 0.5×	26 0.2×	62 0.6×	69 0.8×	40	368
Mehmet Uğur Mungan Türkiye	13	65 0.4×	24 0.1×	187 1.3×	35 0.3×	26 0.3×	27	425
Qianxu Guo United States	7	52 0.3×	32 0.2×	45 0.3×	40 0.4×	25 0.3×	9	323
H. E. Reis Germany	7	201 1.1×	11 0.1×	289 1.9×	24 0.2×	9 0.1×	20	479
John P. Farnen United States	9	49 0.3×	53 0.3×	32 0.2×	63 0.6×	12 0.1×	16	265
Pu Ni United States	10	50 0.3×	44 0.3×	69 0.5×	55 0.5×	70 0.9×	23	416
Jen Kou Lin Taiwan	10	219 1.2×	13 0.1×	117 0.8×	68 0.6×	9 0.1×	16	436
Seung Taek Lim South Korea	12	127 0.7×	20 0.1×	41 0.3×	59 0.5×	11 0.1×	35	324
M. Dicato Luxembourg	8	65 0.4×	84 0.5×	26 0.2×	46 0.4×	7 0.1×	20	243

Countries citing papers authored by G. Martignoni

Since Specialization

Citations

This map shows the geographic impact of G. Martignoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Martignoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Martignoni more than expected).

Fields of papers citing papers by G. Martignoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Martignoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Martignoni. The network helps show where G. Martignoni may publish in the future.

Co-authorship network of co-authors of G. Martignoni

This figure shows the co-authorship network connecting the top 25 collaborators of G. Martignoni. A scholar is included among the top collaborators of G. Martignoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Martignoni. G. Martignoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martignoni, G., et al.. (2012). Bowen's disease in a renal transplant recipient treated with a single application of topical imiquimod: severe adverse skin reaction with favourable clinical outcome.. PubMed. 83(1). 81–3.

Novara, Giacomo, Wassim Kassouf, J.T. Walton, et al.. (2010). 38 LYMPHOVASCULAR INVASION IS A PATHOLOGIC FEATURE OF BIOLOGICALLY AGGRESSIVE DISEASE IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT: AN INTERNATIONAL EXTERNAL VALIDATION STUDY. European Urology Supplements. 9(2). 46–46. 1 indexed citations

Novara, Giacomo, Vincenzo De Marco, Orietta Dalpiaz, et al.. (2008). INDEPENDENT PREDICTORS OF METACHRONOUS BLADDER TRANSITIONAL CELL CARCINOMA AFTER NEPHROURETERECTOMY FOR TRANSITIONAL CELL CARCINOMA OF THE UPPER URINARY TRACT. European Urology Supplements. 7(3). 136–136. 1 indexed citations

Pirovano, M, et al.. (2007). Impact on therapeutic index of a chronomodulated infusion at conventional doses of oxaliplatin (OHP), 5-fluorouracil (5-FU) and folinic acid (AF) in not previously treated metastatic colorectal cancer patients: A multicentric observational study. Journal of Clinical Oncology. 25(18_suppl). 14572–14572. 1 indexed citations

Pirovano, M, Stefano Sestini, Federica Gherardi, et al.. (2006). Pharmacokinetics of Irinotecan and SN38 after intra-arterial liver perfusion according to infusion time and circadian patient pattern in metastatic colorectal cancer. Journal of Clinical Oncology. 24(18_suppl). 13557–13557. 1 indexed citations

Cascinu, Stefano, Mario Scartozzi, Roberto Labianca, et al.. (2004). High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). British Journal of Cancer. 90(8). 1521–1525. 49 indexed citations

Beretta, Giordano, Vittorio Ferrari, Sandro Barni, et al.. (2002). Medical Treatment of Colorectal Cancer in Elderly (>70 Years): Giscad Experience and Future Perspectives. Tumori Journal. 88(1_suppl1). S109–S112. 2 indexed citations

Porcaro, Antonio Benito, Stefano Zecchini Antoniolli, Giovanni Novella, et al.. (2001). [Histopathologic risk factors in patients with non-seminomatous germ tumors of the testis in clinical stage 1. Retrospective study of 75 patients].. PubMed. 73(4). 177–80.

Cascinu, Stefano, Roberto Labianca, Sandro Barni, et al.. (1999). A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer. Annals of Oncology. 10(8). 985–987. 5 indexed citations

10.

Labianca, Roberto, Stefano Cascinu, L. Frontini, et al.. (1997). High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study. Annals of Oncology. 8(2). 169–174. 20 indexed citations

11.

Cascinu, Stefano, Roberto Labianca, Paolo Alessandroni, et al.. (1997). Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.. Journal of Clinical Oncology. 15(11). 3313–3319. 88 indexed citations

12.

Zaniboni, Alberto, Roberto Labianca, G. Martignoni, et al.. (1996). Sequential Methotrexate and 5-Fluorouracil as Second-Line Chemotherapy for Advanced Colorectal Cancer Patients Pretreated with 5-Fluorouracil and Leucovorin: a GISCAD Study. Journal of Chemotherapy. 8(1). 82–84. 6 indexed citations

13.

Labianca, Roberto, Sandro Barni, G. Ambrosini, et al.. (1994). Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience. European Journal of Cancer. 30(11). 1611–1616. 8 indexed citations

14.

Labianca, Roberto, G. Pancera, Sandro Barni, et al.. (1993). Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer).. PubMed. 339. 233–7. 1 indexed citations

15.

Labianca, Roberto, G. Pancera, Enrico Aitini, et al.. (1991). Folinic acid + 5-Fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of ‘GISCAD’ (Italian Group for the Study of Digestive Tract Cancer). Annals of Oncology. 2(9). 673–679. 57 indexed citations

16.

Agostoni, Angelo, Marco Cicardi, G. Martignoni, Luigi Bergamaschini, & Bianca Marasini. (1980). Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema. Journal of Allergy and Clinical Immunology. 65(1). 75–79. 71 indexed citations

17.

Marasini, Bianca, Marco Cicardi, G. Martignoni, & A Agostoni. (1978). Treatment of hereditary angioedema. Journal of Molecular Medicine. 56(16). 819–823. 36 indexed citations

18.

Agostoni, A, Bianca Marasini, Marco Cicardi, G. Martignoni, & Oreste V. Brenna. (1977). [Study by means of enzymatic and immunochemical determination of Cl esterase inhibitor in 59 patients with hereditary angioneurotic edema].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 56(1). 22–8. 1 indexed citations

19.

Agostoni, A, et al.. (1975). Hereditary angioneurotic oedema. Journal of Molecular Medicine. 53(14). 679–684. 3 indexed citations

20.

Martignoni, G., Bianca Marasini, & A Agostoni. (1974). L'ANGIOEDEMA EREDITARIO. 4(4). 501–513. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact